SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Trading Update

2 Nov 2021 07:00

RNS Number : 9940Q
Warpaint London PLC
02 November 2021
 

2 November 2021

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Trading Update

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands is pleased to announce an update on current trading.

 

Following a continuation of the improving trends seen in the first half of the year, and outlined in the Company's interim results announcement on 22 September 2021, the Company now expects its results for the year ending 31 December 2021 to be ahead of market expectations.

 

Sales for the year ending 31 December 2021 are now expected to be similar to those achieved in 2019 (2020: £40.3 million, 2019: £49.3 million), the most recent financial year that experienced no impact from the Covid-19 pandemic. This has been driven by growth both from existing customers and those new to the Group, and is despite continuing Covid-19 related disruption in 2021, particularly with government imposed lockdowns in the early part of the year.

 

Gross margins are currently being maintained ahead of those achieved in 2020 and 2019 (2020: 31.1%, 2019: 33.5%), despite some increased costs in the supply chain, particularly with freight. The Company therefore anticipates that the Group's Adjusted EBITDA* (2020: £4.2 million, 2019: £7.0 million) and Adjusted Profit Before Tax** (2020: £2.3 million, 2019: £5.2 million) for the year ending 31 December 2021 will be ahead of 2019 and current market expectations, and the performance delivered in 2020.

 

The previously declared interim dividend of 2.5p per share will be paid on 26 November 2021 to shareholders on the register at 12 November 2021. The shares will go ex-dividend on 11 November 2021.

 

* Adjusted for foreign exchange movements, share based payments and exceptional items.

** Adjusted for exceptional costs, amortisation of intangible assets, and share based payments. Adjusted numbers are close to the underlying cash flow performance of the business which is regularly monitored and measured by management.

 

Commenting, Sam Bazini Chief Executive, said: "I am pleased to report that the encouraging trends experienced in the first half of 2021 have continued. We are continuing to see particularly strong growth in the UK, significant growth elsewhere internationally and further increases in online sales.

 

"In line with our stated strategy, we have significant opportunities for further growth, both with our existing retailers, those such as Boots where we are expecting to launch soon, and with others that we are in discussions with. I look forward to the remainder of the year and into 2022 with a high degree of confidence."

 

 

Enquiries:

Warpaint London

c/o IFC

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Finance Officer

Singer Capital Markets (Nominated Adviser & Joint Broker)

020 7496 3000

Shaun Dobson, Tom Salvesen, Jen Boorer, Alex Bond - Investment Banking

Shore Capital (Joint Broker)

020 7408 4090

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection, Very Vegan, and Chit Chat.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSLEFFEFSELF
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM and Posting of Annual Report
29th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSNotice of Results
9th Apr 20269:41 amRNSBlock Listing Return
17th Feb 20261:34 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSRule 19.6(c) confirmation re Brand Architekts
9th Feb 20262:21 pmRNSCompletion of the acquisition of the Barry M brand
9th Feb 20267:00 amRNSAcquisition of Barry M brand & FY25 Trading Update
24th Nov 202512:16 pmRNSHolding(s) in Company
10th Nov 20252:06 pmRNSBLOCK LISTING RETURN
29th Oct 20252:52 pmRNSHolding(s) in Company
9th Oct 20251:36 pmRNSBlock listing Return
8th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
17th Sep 20259:12 amRNSHolding(s) in Company
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Results
21st Aug 20252:23 pmRNSHolding(s) in Company
19th Aug 20258:21 amRNSHolding(s) in Company
17th Jun 202510:46 amRNSResult of AGM
17th Jun 20257:00 amRNSAGM Statement
28th May 20252:43 pmRNSHolding(s) in Company
20th May 202512:01 pmRNSHolding(s) in Company
20th May 20257:30 amRNSNotice of AGM and Posting of Annual Report
13th May 20254:54 pmRNSBlock listing Interim Return
29th Apr 20257:00 amRNSResults for the year ended 31 December 2024
14th Apr 20257:00 amRNSNotice of Results
9th Apr 20253:07 pmRNSBLOCK LISTING RETURN
24th Mar 20251:38 pmRNSAnnouncement pursuant to AIM rule 13
13th Feb 20253:18 pmGNWForm 8.3 - Warpaint London Plc
13th Feb 20251:52 pmRNSForm 8.3 - Warpaint London plc
13th Feb 202512:17 pmRNSForm 8.3 - Warpaint London Plc
13th Feb 202511:50 amRNSForm 8.5 (EPT/RI)
13th Feb 202511:24 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
12th Feb 20255:56 pmRNSForm 8.3 - Warpaint London plc Amend
12th Feb 20253:46 pmRNSDirector/PDMR Dealing
12th Feb 20253:37 pmRNSApplication for Admission of Shares and TVR
12th Feb 20253:25 pmRNSReplacement: Scheme Effective
12th Feb 20253:10 pmRNSForm 8.3 - Warpaint London plc
12th Feb 20252:41 pmGNWForm 8.3 - Warpaint London Plc
12th Feb 20252:19 pmRNSForm 8.3 - Warpaint London Plc
12th Feb 202512:05 pmPRNForm 8.3 - Warpaint London Plc
12th Feb 202511:48 amRNSForm 8.3 - Warpaint London plc
12th Feb 202511:35 amRNSForm 8.3 - Warpaint London PLC
12th Feb 202510:59 amRNSForm 8.5 (EPT/RI)
12th Feb 202510:54 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 20253:04 pmGNWForm 8.3 - Warpaint London Plc
11th Feb 202512:19 pmRNSForm 8.3 - Warpaint London plc
11th Feb 202511:03 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 202510:49 amRNSForm 8.5 (EPT/RI)
11th Feb 202510:36 amRNSForm 8.3 - Warpaint London plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.